<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180929041170N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-09</date_registration>
      <primary_sponsor>Oroumia University of Medical Sciences</primary_sponsor>
      <public_title>"The impact of education based on Health Belief Model on the belief to vaccination of the Human papillomavirus."</public_title>
      <acronym>HPV</acronym>
      <scientific_title>Investigating the effect of educational intervention based on Health Belief Model on the belief to vaccination of human papillomavirus in female  nursing students of Governemental Nursing and Midwifery School in West Azarbayjan Province in 2017-2018.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34523</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Education/Guidance, Other design features: A pre-test will be performed through a questionnaire from both intervention and control groups. In the intervention group; an intervention will be conducted. Post-test at the last training session and then one month after the intervention(follow up) in the intervention group and one month after the post-test in the control group in both colleges will be done, Randomization description: Simple randomization; Individual randomization unit; randomization tool use sealed envelope.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Vaccination of Human papillomavirus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In intervention group, educational intervention during 4 sessions, each session lasted for at least 45 minutes to 1 hour with one session per week( about Human papillomavirus infection, symptoms, complications, risk factors, prospects of the disease in Iran and the world, the high-risk behaviors of the infection in people, the effects of the disease on the different dimensions of health and the importance of prevention and the benefits of vaccination) by lecture and using power point software, as well as questions and answers, providing educational pamphlets and educational booklet and also educational Messages will be done. Intervention 2: Control group: In the control group, no intervention will be applied.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Publishing research results in the form of an article in a scientific publication

When:
The beginning of the access period is 6 months after the publication of the article.

To whom:
Public

Conditions:
To inform the people about the Human papillomavirus vaccination.

Where to obtain:
Dr Rogaye  Bayrami, Assistant Professor of Urmia Nursing Midwifery School
 E-mail: rozabayrami@yahoo.com

How to obtain:
Login to Urmia University of Medical Sciences Web Site and search for thesis

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Bita Ghorbani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Nazlou Campus., Urmia University of Medical Sciences</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5756115111</zip>
        <telephone>+98 44327549614</telephone>
        <email>ghorbanibitaa@gmail.com</email>
        <affiliation>Urmia Nursing and Midwifery School</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Roghieh Bayrami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Nazlou Campus., Urmia University of Medical Sciences</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5756115111</zip>
        <telephone>+98 44327549614</telephone>
        <email>rozabayrami@yahoo.com</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female nursing students
The age  range between 18 - 26 years old
Single students</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>26 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Age above 26 years old
Being married
History of vaccination of the Human papillomavirus
The history of genital warts</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>XXI</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Factors influencing health status and contact with health services</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In intervention group, educational intervention during 4 sessions, each session lasted for at least 45 minutes to 1 hour with one session per week( about Human papillomavirus infection, symptoms, complications, risk factors, prospects of the disease in Iran and the world, the high-risk behaviors of the infection in people, the effects of the disease on the different dimensions of health and the importance of prevention and the benefits of vaccination) by lecture and using power point software, as well as questions and answers, providing educational pamphlets and educational booklet and also educational Messages will be done.</i_keyword>
      <i_keyword>Control group: In the control group, no intervention will be applied.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Belief. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: The overall score obtained from Questionnaire created based on Health Belief Model.</prim_outcome>
      <prim_outcome>Knowledge. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created: correct؛ wrong and I do not know.</prim_outcome>
      <prim_outcome>Perceived susceptibility. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created based on Health Belief Model.</prim_outcome>
      <prim_outcome>Perceived severity. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created based on Health Belief Model.</prim_outcome>
      <prim_outcome>Perceived benefits. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created based on Health Belief Model.</prim_outcome>
      <prim_outcome>Perceived barriers. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created based on Health Belief Model.</prim_outcome>
      <prim_outcome>Self efficacy. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created based on Health Belief Model.</prim_outcome>
      <prim_outcome>Cues to action. Timepoint: Pretest (Before intervention، post test( last intervention session) and follow up( a months after last intervention session). Method of measurement: Questionnaire created: yes and no.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Belief. Timepoint: follow up(a months after last intervention session). Method of measurement: The overall score obtained from Questionnaire created based on Health Belief Model.</sec_outcome>
      <sec_outcome>Knowledge. Timepoint: follow up(a months after last intervention session). Method of measurement: Questionnaire created: correct؛ wrong and I do not know.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Oroumia University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-08-15</approval_date>
        <contact_name>Ethics committee of Urmia  University of Medical Sciences</contact_name>
        <contact_address>Emergency Ave, Resalat Blvd, Urmia Urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
